Navigating the open innovation paradox: an integrative framework for adopting open innovation in pharmaceutical R&D in developing countries
{{output}}
In this paper, we combine evidence from eight Indian pharmaceutical firms with extant literature and global best practices to conceptualize an integrative framework addressing the open innovation paradox (OIP), i.e., the tension between intellectual protection... ...
